Home
Onco360

Onco360 Market Share Analysis for August 2026

Patient Resources Archive - Onco360

Health > Health - Other

Domainonco360.com

Year Founded2003

Employees501 - 1000

Annual Revenue$100M - $200M

Onco360

Onco360 (including company regionals)

onco360.com

See more website traffic and engagement information

Onco360 Revenue up to August 2026 is 100M - 200M

revenue generated by Onco360 top domains

Onco360 top domains revenue over 3 years

Revenue for Onco360 top domains

onco360.com100M - 200M

See more with Sales Intelligence

Total visits to Onco360's top domains

Understand Onco360 market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

onco360.com15.1K

See more with Sales Intelligence

Avg. visit duration in Onco360's top domains

Analyze Onco360 engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

onco360.com00:00:49

See more with Sales Intelligence

Avg. pageviews on Onco360's top domains

See how Onco360 keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

onco360.com1.70

See more with Sales Intelligence

Onco360 top competitors by domain

Top similar sites in August 2026, ranked by their affinity

accredo.comCompany NameAccredoEmployees1001 - 5000HQUnited States, Tennessee, MemphisAnnual revenue> $1BTotal visits354.3KHealth > Health - Other

Top technologies used by Onco360

These are the website technologies, by industry, used by Onco360 top domains

Widget (7)

Twemoji

Advertising (5)

Google Adsense

Email Services (4)

Sendgrid

Social (3)

Instagram

More Technologies

11

See all

News & Signals from Onco360

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOnco360, Inc. partnered with Takeda Pharmaceutical Co. on Sep 9th '26.For investors, Onco360's strong partnership with a reputable pharmaceutical giant like Takeda can enhance stock performance and market confidence.

NewsOnco360 partnered with Rigel Pharmaceuticals, Inc. on Jul 29th '26.LOUISVILLE, Ky., July 29, 2026 (GLOBE NEWSWIRE) - Onco360(R), the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Rigel Pharmaceuticals for VEPPANU(TM)(vepdegestrant), which is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.[1]

NewsOnco360, Inc. recognized as national Specialty Pharmacy partner for Komzifti on Jun 4th '26.Onco360 has been selected as a national Specialty Pharmacy partner for Komzifti(TM)(ziftomenib).